The effects of non-compliance on intent-to-treat analysis of equivalence trials
- 11 October 2005
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 25 (7) , 1183-1199
Abstract
The standard approach for analysing a randomized clinical trial is based on intent-to-treat (ITT) where subjects are analysed according to their assigned treatment group regardless of actual adherence to the treatment protocol. For therapeutic equivalence trials, it is a common concern that an ITT analysis increases the chance of erroneously concluding equivalence. In this paper, we formally investigate the impact of non-compliance on an ITT analysis of equivalence trials with a binary outcome. We assume ‘all-or-none’ compliance and independence between compliance and the outcome. Our results indicate that non-compliance does not always make it easier to demonstrate equivalence. The direction and magnitude of changes in the type I error rate and power of the study depend on the patterns of non-compliance, event probabilities, the margin of equivalence and other factors. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- A score test for binary data with patient non-complianceStatistics in Medicine, 2003
- Therapeutic equivalence: fallacies and falsificationStatistics in Medicine, 2003
- Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statisticsStatistics in Medicine, 2002
- Choice of Delta in Equivalence TestingDrug Information Journal, 2001
- Some Issues in the Design and Analysis of Equivalence TrialsDrug Information Journal, 1999
- SURVIVAL ANALYSES OF RANDOMIZED CLINICAL TRIALS ADJUSTED FOR PATIENTS WHO SWITCH TREATMENTSStatistics in Medicine, 1996
- Trials to assess equivalence: the importance of rigorous methods: Fig 1BMJ, 1996
- Intention to treat – who should use ITT?British Journal of Cancer, 1993
- Clinical and statistical issues in therapeutic equivalence trialsEuropean Journal of Clinical Pharmacology, 1993
- Adjusting for early treatment termination in comparative clinical trialsStatistics in Medicine, 1990